Allen Cox
Monday, 4 April 2016
Allergan drops 22% on tax inversion curbs
US Treasury's fresh move to stop companies shifting overseas wipes $20bn from drugmaker's value
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment